Harvard Bioscience to Hold Fourth Quarter Earnings Call
Harvard Bioscience, Inc. (Nasdaq: HBIO) is gearing up to share its financial results for the quarter that ended on December 31, 2024. This important announcement will be made public just before the market opens on March 12, 2025. Investors and stakeholders are encouraged to participate in the subsequent conference call scheduled for 8:00 AM Eastern Time.
Joining the Earnings Call
To join the conference call and participate in the Q&A session, attendees must register in advance. Upon registration, participants will receive crucial dial-in details along with a unique PIN. This process ensures that those who wish to ask questions can do so easily and effectively.
Audio Webcast Details
For those preferring audio-only webcasts, the company will provide a link on its investor website where individuals can tune in. This allows for wider access to the earnings call and ensures that everyone has the opportunity to stay informed on the latest developments at Harvard Bioscience.
Financial Information Availability
As part of the earnings call, financial information including the earnings release and an accompanying slide presentation will be readily available in the Investor Relations section on Harvard Bioscience’s website. This transparency enables stakeholders to better understand the company’s performance and strategic direction.
About Harvard Bioscience
Harvard Bioscience, Inc. stands out as a premier innovator in the development, manufacturing, and sale of cutting-edge technologies, products, and services aimed at advancing life science applications. Whether it's for research, pharmaceutical discovery, bio-production, or preclinical testing, the company's solutions are vital across various sectors. Harvard Bioscience proudly serves a diverse customer base, including distinguished academic institutions, government laboratories, and leading organizations in pharmaceuticals and biotechnology.
Global Reach and Customer Base
With a strong international presence in regions such as the United States, Europe, and China, Harvard Bioscience utilizes both direct sales and distribution channels to extend its impact globally. Their commitment to supporting scientific advancement is reflected in their continued partnership with laboratories and research entities worldwide.
Contact Information
For further inquiries, Jennifer Cote, the Chief Financial Officer, can be reached directly at (508) 893-3120. Additionally, for investor-related questions, Sandy Martin from Three Part Advisors is available at (214) 616-2207 or via email.
Frequently Asked Questions
What is the date of the earnings call?
The earnings call is scheduled for March 12, 2025, at 8:00 AM Eastern Time.
How can I participate in the conference call?
Participants must register in advance to receive the call's dial-in numbers and a unique PIN.
Where can I find the financial results during the call?
The financial results, along with a slide presentation, will be posted on the Investor Relations section of Harvard Bioscience's website.
Who can I contact for more information?
For inquiries, contact Jennifer Cote at (508) 893-3120 or reach out to Sandy Martin at (214) 616-2207 for investor questions.
What services does Harvard Bioscience offer?
Harvard Bioscience provides technologies and services for life sciences applications, including research, bio-production, and pharmaceutical development.
